Adalimumab

Adalimumab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNFα). Adalimumab has been used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
Supplier BOC Sciences
Product # 331731-18-1
Pricing Inquire
Cas 331731-18-1
Molecular Weight 144 kDa
Molecular Formula C6428H9912N1694O1987S46
Feedback